Just ask Howarth, Jooste, and Handa about what Pfizer is doing?
Tight control of the share price just like they did to Icagen before having to declare a 10% position.
So, so obvious... UNTIL LARGE Hedge Funds and Deep Pocket Retailers off the Caymans hit the "buy" button, Pfizer's front team will continue to hold this down. After all, Antares management is remaining strangely quiet given all the opportunity for news.
This is what I speculated on a week or two ago and some folks thought I was nuts. Or you read it and are regurgitating. It seems plausible with the deep pockets PFE has. Why not accumulate through the same techniques a MM does? Accumulate so the net purchase price is significantly less. No disclosure issues i believe? BSAV might weigh in on that possibly?